NCT02823626View on ClinicalTrials.gov

High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Acute Decompensated Heart Failure
Interventions
DRUG

Spironolactone and patiromer

High dose spironolactone with or without patiromer based on the patient's baseline potassium

Trial Locations (1)

78229

Shweta Bansal, San Antonio

All Listed Sponsors
collaborator

Relypsa, Inc.

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT02823626 - High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure | Biotech Hunter | Biotech Hunter